The company’s consolidated revenue for 2018-19 stood at Rs 9,865.46 crore, compared to Rs 9,103.07 crore in the preceding fiscal.
Drug firm Glenmark Pharmaceuticals May 29 reported a 6.62 per cent rise in its consolidated net profit to Rs 161.66 crore for the fourth quarter ended March 31. The company had posted a net profit of Rs 151.62 crore for the corresponding period previous fiscal, Glenmark Pharmaceuticals said in a BSE filing.
Consolidated revenue of the company stood at Rs 2,563.47 crore for the quarter under consideration. It was Rs 2,279.81 crore during the same period a year ago.
For the fiscal year ended March this year, the company posted a net profit of Rs 924.99 crore as against Rs 803.87 crore for the previous fiscal.